Cited by 940Cancer Immunotherapy and BiomarkersT-cell and B-cell ImmunologyImmunotherapy and Immune Responses

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

CTLA-4: new insights into its biological function and use in tumor immunotherapy

Egen, Jackson G., Kuhns, Michael S., Allison, James P.·2002·Nature Immunology

Open this paper in CoChat — free account

Abstract

The discovery of multiple costimulatory cell surface molecules that influence the course of T cell activation has increased our appreciation of the complexity of the T cell response. It remains clear, however, that CD28 and cytotoxic T lymphocyte antigen 4 (CTLA-4) are the critical costimulatory receptors that determine the early outcome of stimulation through the T cell antigen receptor (TCR). Details of how the T cell integrates TCR stimulation with the costimulatory signals of CD28 and the inhibitory signals of CTLA-4 remain to be established, but unique features of the cell biology of CTLA-4 provide important insights into its function. We summarize here recent findings that suggest a previously unrecognized role for CTLA-4 in the regulation of T cell responses. We also describe preclinical and clinical results that indicate manipulation of CTLA-4 has considerable promise as a strategy for the immunotherapy of cancer.

Integrity signals

Registry

Crossref · 10.1038/ni0702-611

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955
Self-citation
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.
Dranoff, G., Jaffee, E. M., Lazenby, A., Golumbek, P. T., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D. M., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,820
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245
Self-citation
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation
Read, S., Malmström, V., & Powrie, F. M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,206
B7/CD28 Costimulation Is Essential for the Homeostasis of the CD4+CD25+ Immunoregulatory T Cells that Control Autoimmune Diabetes
Salomon, B. L., Lenschow, D. J., Rhee, L., Ashourian, N., Singh, B., Sharpe, A. H., & Bluestone, J. A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80195-8 · Cited by 2,058
The B7–CD28 superfamily
Sharpe, A. H., & Freeman, G. J. (2002) · Nature reviews. Immunology · doi:10.1038/nri727 · Cited by 1,759

Show all 93 references

Sorted by citations

Items 801–900 of 940

DNA Vaccines
Bereta, M., & Kaufman, H. L. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-680-5_16 · Cited by 1
Immuno-Oncology In Cancer Cervix Treatments: Literature Review
Naser, M., Nasr, M., & Shehata, L. H. (2023) · International Journal of Progressive Sciences and Technologies · doi:10.52155/ijpsat.v41.1.5708 · Cited by 1
Revolutionizing cancer treatment: an in-depth exploration of CAR-T cell therapies
Kandav, G., & Chandel, A. (2024) · Medical Oncology · doi:10.1007/s12032-024-02491-6 · Cited by 1
Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
Ramos, B., & Rogers, D. (2025) · annals of urologic oncology · doi:10.32948/auo.2025.02.01 · Cited by 1
Cytotoxic T Lymphocytes and Their Granzymes: An Overview
Noonan, J., & Murphy, B. M. (2015) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-17807-3_5 · Cited by 1
Radiation Immune Modulation Therapy of Glioma
Bertil, R. R. (2011) · InTech eBooks · doi:10.5772/22560 · Cited by 1
Strategies to Target Tumor Immunosuppression
Draghiciu, O., Nijman, H. W., & Daemen, T. (2014) · Springer eBooks · doi:10.1007/978-3-662-44946-2_5 · Cited by 1
5 Can Effector Cells Really “Effect” an Anti-Tumor Response as Cancer Therapy?
Slovin Susan, F. (2005) · Handbook of immunohistochemistry and in situ hybridization of human carcinomas · doi:10.1016/s1874-5784(05)80060-1 · Cited by 1
Tumor Antigens Revealed by Exome Seqeuncing Drive Editing of Tumor Immunogenicity
Vesely, M. D. (2013) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7c8278n · Cited by 1
Review paper The role of abatacept in the treatment of rheumatoid arthritis
Wiland, P., Kowalewska, B., Roszkowska, E., & Szechiński, J. (2007) · Cited by 1
Immunity to Cancers
Male, D. K., Brostoff, J., Roth, D. B., & Roitt, I. M. (2006) · Elsevier eBooks · doi:10.1016/b0-323-03399-7/50024-6 · Cited by 1
Autoantibodies in Alcohol-Related Tissue Diseases This work has been supported by a grant from the Regional Government of Piedmont.
Albano, E., & Vidali, M. (2005) · Elsevier eBooks · doi:10.1016/b978-012564370-2/50096-9 · Cited by 1
Regulatory T Cells in Colorectal Cancer
Jafariniaorcid, M., Lotfiorcid, N., Ganjalikhani-hakmiorcid, M., & Rezaei, A. (2018) · Immunoregulation · doi:10.32598/immunoregulation.1.1.5 · Cited by 1
Role of Regulatory T Lymphocytes in Health and Disease
Shokeen, N., Saini, C., Sapra, L., Azam, Z., Bhardwaj, A., Ahmad, A., & Srivastava, R. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-3350-1_8 · Cited by 1
Biologic Therapies
Eisenberg, R. A., & Behrens, E. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29875-9.00017-3 · Cited by 1
Immunotherapies
Bignold, L. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816920-9.00016-x · Cited by 1
Immunotherapy: Targeting Cancer Cells
Vindhya, M., Bharadwaj, M. N. R., Basalingappa, K. M., Gopenath, T. S., & Gnanasekaran, A. (2023) · Biological and medical physics, biomedical engineering · doi:10.1007/978-981-19-9786-0_5 · Cited by 1
Biological therapies for cancer
Rao, G. K., Fuller, C. L., & Price, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13344-2.00010-9 · Cited by 1
Pattern Recognition Receptors and Aging
Shalaby, K. H. (2013) · Springer eBooks · doi:10.1007/978-3-642-39495-9_8 · Cited by 1
Genetic and immunological control of human myasthenia gravis
Zhao, X. (2005) · Figshare · Cited by 1
NanoAPC deliver antigen, IL-2 and co-stimulatory molecules to antigen specific T cells and activate viral specific T cells in chronic infections
Liu, M. (2011) · Brunel University Research Archive (BURA) (Brunel University London) · Cited by 1
Diabetes is not prevented by Foxp3-transduced CD4+T cells under the IL-12Rβ2 promoter control
Wang, R., Han, G., Wang, J., Song, L., Chen, G., Xu, R., Wang, L., Li, X., Shen, B., & Li, Y. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.05.016 · Cited by 1
Immuno- and gene-therapeutic strategies targeted against cancer (mainly focusing on pancreatic cancer)
Yoshimura, K., Olino, K. L., Edil, B. H., Schulick, R. D., & Oka, M. (2010) · Surgery Today · doi:10.1007/s00595-009-4120-8 · Cited by 1
Request for Reprints
Ramanan, S. V. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.20.2509-a · Cited by 1
CD137/CD137 Ligand in Tumor and Viral Immunotherapy
Melero, I., Murillo, O., Tirapu, I., Huarte, E., Arina, A., Arribillaga, L., & Lasarte, J. J. (2007) · Springer eBooks · doi:10.1007/0-387-32829-7_8 · Cited by 1
Etiology of Autoimmmune Disease
Sercarz, E. E., & Gabaglia, C. R. (2007) · Methods in molecular biology · doi:10.1007/978-1-59745-395-0_16 · Cited by 1
New Approaches for Optimizing Melanoma Vaccines
Vohra, N. A., Pilon‐Thomas, S., Mulé, J. J., & Weber, J. S. (2008) · CRC Press eBooks · doi:10.3109/9781420020328.011 · Cited by 1
Multiple Chemotherapy-Based Combination Therapy Strategies for Advanced Lung Cancer Patients: A Systematic Review and Network Meta-AnalysisPreprint
Xiong, L., Bai, Y., Zhou, X., Xu, M., Pan, G., Zhao, J., & Tang, H. (2020) · Preprints.org · doi:10.20944/preprints202005.0478.v1 · Cited by 1
Optimizing mechanostable anchor points of engineered lipocalin in complex with CTLA-4Preprint
Liu, Z., Moreira, R. A., Dujmović, A., Liu, H., Yang, B., Poma, A. B., & Nash, M. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.09.434559 · Cited by 1
HLA Class I Antigen-Processing Machinery and HLA Class I Antigen-Derived Peptide-Complex Defects in Tumor-Cell Escape
Campoli, M. R., Chang, C., Wang, X., & Ferrone, S. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-743-7_1 · Cited by 1
Vakzinierungen in der Therapie des Mammakarzinoms
Gückel, B. (2006) · Der Onkologe · doi:10.1007/s00761-005-0999-x · Cited by 1
Construction of CTLA-4-Ig Fusion Gene in pBudCE4.1 Expression Vector.
Yazdanpanah‐Samani, M., Maymand, E. M., Jahangeerfam, T., & Ghaderi, A. A. (2015) · Europe PMC (PubMed Central)
Treatment with Monoclonal Antibodies
Schwab, G. M., Roskos, L. K., & Davis, C. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-664-5_17
T cells and smoke-induced airway inflammation
Mikko, M. (2010) · Figshare
Immunotherapy for Prostate Cancer
So-Rosillo, R., & Small, E. J. (2006) · American Journal of Cancer · doi:10.2165/00024669-200605050-00004
Multiple costimulatory modalities enhance CTL avidity.
Garnett‐Benson, C., Chakraborty, M., Kudo‐Saito, C., Schlom, J., & Hodge, J. W. (2006) · Cancer Research
CD4+ T Cell Responses: A Complex Network of Activating and Tolerizing Signals as Revealed by Gene Expression Analysis: A Dissertation
Brown, D. S. (2005) · eScholarship@UMassChan · doi:10.13028/eqwy-6j58
The Role of Dendritic Cells in T‐cell Activation and Differentiation
Sallusto, F., & Lanzavecchia, A. (2006) · Wiley eBooks · doi:10.1002/9783527619696.ch18
Immunology of Cancer
Holman, P., & Ball, E. D. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200400074
Caracterização da resposta imune celular pela expressão imunoistoquímica de CD4, CD8, CD28, CD152, CD56 e FOXP3 em carcinoma mamário de fêmeas caninas
Tiosso, C. D. F. (2012) · Aleph UCLA Undergraduate Research Journal for the Humanities and Social Sciences
CTLA-4 Exon One +49A/G Gene Variants in Patients with Superficial and Invasive Bladder Cancer: A Study in Southern Iran
Aminsharifi, A., Ghaderi, A. A., Naeimi, S., Khezri, A., Agahi, N., Aminian, A., & Zamiri, N. (2010) · DOAJ (DOAJ: Directory of Open Access Journals)
New strategies for allogeneic hematopoietic stem cell transplantation with umbilical cord
Gertow, J. (2013) · Figshare
Immunomodulatory Molecules of the Immune System
Saenger, Y. M., Jenq, R. R., & Perales, M. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_5
B Cell Central Tolerance: Controlling Self-Reactive B Cells in the Bone Marrow
Diamant, E., & Melamed, D. (2014) · Springer eBooks · doi:10.1007/978-0-387-84828-0_562
Population Genetic Principles and Human Populations
Dermitzakis, E. T. (2009) · Springer eBooks · doi:10.1007/978-3-540-37654-5_18
Cancer vaccines: is there a future?
STREICHER, H. Z. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.6.617
Antibody-based cancer therapy
Baxevanis, C. N. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.4.441
In situ tumor destruction: towards in vivo modulation of immune responses by dendritic cells.
den Brok, M. H. M. G. M. (2006) · Radboud Repository (Radboud University)
Chemoprevention of Familial Melanoma
Hariharan, V. (2011) · Loyola eCommons (Loyola University of Chicago)
Mechanisms of negative costimulation by CTLA-4 and its manipulation in tumor immunotherapy in mice and man
Allison, J. P. (2003) · Cancer immunity
Self-citation
Semantic Modeling for SNPs Associated with Ethnic Disparities in HapMap Samples
Kim, H., Yoo, W. G., Park, J., Kim, H., & Kang, B.-C. (2014) · Genomics & Informatics · doi:10.5808/gi.2014.12.1.35
Autoantibodies as markers of beta-cell autoimmunity in children
Holmberg, H. (2006) · DiVA (Linkoping University)
Gut Infection in HIV: Past, Present and Future
Portsmouth, S., Stebbing, J., & Gazzard, B. (2003) · Springer eBooks · doi:10.1007/978-88-470-2091-7_31
Generation of antigen-specific T cell immunity through T cell receptor gene transfer
Coccoris, M. (2009) · Leiden Repository (Leiden University)
Meta-Analysis of Genome-Wide Association Studies in Celiac Disease and Rheumatoid Arthritis Identifies Fourteen Non-HLA
Loci, S. (2016)
Tumor Vaccines in Leukemia
Borrello, I. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-322-6_16
T Cells and Antigen Recognition
Emens, L. A. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_3
Tumor-Induced Immune Suppression and Immune Escape
Campoli, M. R., & Ferrone, S. (2006) · Humana Press eBooks · doi:10.1385/1-59745-011-1:263
Cancer Immunology, Immunotherapeutics, and Vaccine Approaches
Madan, R. A., Gulley, J. L., Celestin, J., Arlen, P. M., & Schlom, J. (2010) · Springer eBooks · doi:10.1007/978-1-60327-829-4_27
Mechanismen der Autoimmunität
Kasperkiewicz, M., & Zillikens, D. (2006) · Aktuelle Dermatologie · doi:10.1055/s-2006-944623
The neonatal immune system: modulation by regulatory T-cells and CTLA-4 (CD152)1)
Hebel, K., Pierau, M., Lingel, H., STEINER, M. C., Krause, H., Jorch, G., & Brunner-Weinzierl, M. C. (2013) · Journal of Laboratory Medicine · doi:10.1515/labmed-2013-0067
Das neonatale Immunsystem: Modulation durch regulatorische T-Zellen und CTLA-4 (CD152)
Hebel, K., Pierau, M., Lingel, H., Steiner, M., Krause, H., Jorch, G., & Brunner-Weinzierl, M. C. (2013) · Journal of Laboratory Medicine · doi:10.1515/labmed-2012-0061
A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers Supplementary Issue: Targeted Therapies in Breast Cancer Treatment
Bryan, M. (2015)
Immunologic Approaches to Prostate Cancer
Fong, L. H., & Small, E. J. (2006) · Translational medicine series · doi:10.3109/9781420019858.006
REVISIONES El potencial de la inmunomodulación con anticuerpos monoclonales anti-CD137 (4-1BB) para terapia de enfermedades malignas e infecciones virales crónicas The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases
Alfaro, C., Murillo, O., Tirapu, I., Azpilicueta, A., Huarte, E., Arina, A., Arribillaga, L., Bendandi, M., Prìeto, J., Lasarte, J. J., et al. (2006)
Immunomodulation induced by oral uptake of nickel (Ni)
Krutmann, J. (2005)
4.24 Biomaterials in Vaccine and Immunotherapy ☆
Toy, R., & Roy, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.10154-7
Harnessing Eosinophils as a Potential Tumoricidal Immunotherapy
Amini, Z. (2016) · OakTrust (Texas A&M University Libraries)
A GENOME-SCALE CRISPR SCREEN TO IDENTIFY ESSENTIAL GENES FOR THE EFFECTOR FUNCTION OF CYTOTOXIC T LYMPHOCYTES
Patel, S. J. (2017) · DigitalGeorgetown (Georgetown University Library)
The Novel Bispecific Diabody αCD40/αCD28 Strengthens Leukemic Dendritic Cell Induced T Cell Reactivity.
Houtenbos, I., Santegoets, S. J. A. M., Westers, T. M., Waisfisz, Q., Kipriyanov, S. M., Denkers, F., Scheper, R. J., de Gruijl, T. D., Ossenkoppele, G. J., & van de Loosdrecht, A. A. (2006) · Blood · doi:10.1182/blood.v108.11.3710.3710
Ovarian Cancer
Martin, L. P., & Schilder, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803741-6.00008-2
Stellenwert der Immunonkologie bei der Therapie des Urothelkarzinoms
Retz, M. M., Tauber, R., & Horn, T. D. (2017) · Aktuelle Urologie · doi:10.1055/s-0043-107041
Aktuelle Systemtherapie des metastasierten Harnblasenkarzinoms
Horn, T. D., Amsberg, G. V., Tauber, R., & Retz, M. M. (2018) · best practice onkologie · doi:10.1007/s11654-018-0076-8
Combinatorial Checkpoint Blockade Immunotherapy and Radiation
Kim, S. S., & Sharabi, A. B. (2017) · Current cancer research · doi:10.1007/978-3-319-63757-0_6
Immunostimulatory monoclonal antibodies for melanoma treatment
de, S. M. F., Perez-Gracia Jose, L., Salvador, M.-A., & Melero, I. (2012) · doi:10.2217/ebo.11.59
Fortgeschrittenes Urothelkarzinom
Horn, T. D., Krege, S., & Retz, M. M. (2018) · Der Urologe · doi:10.1007/s00120-018-0626-2
Beyond PD-1/PD-L1 Axis Blockade: New Combination Strategies in Metastatic Melanoma Treatment
Giunta, E. F., Argenziano, G., Brancaccio, G., Martinelli, E., Ciardiello, F., & Troiani, T. (2018) · Current Cancer Therapy Reviews · doi:10.2174/1573394714666180927095650
Framing technology challenges associated with improving cancer immunotherapies
Heath, J. R. (2019) · Lab on a Chip · doi:10.1039/c9lc90103e
Search for drug discovery targets focusing on cancer stroma
Kamada, H. (2019) · Translational and Regulatory Sciences · doi:10.33611/trs.1_58
The genetic basis of T and B cell contribution to autoimmune diabetes in NOD mice
Motta, V. N. (2006) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Non-melanoma Skin Cancer and Cutaneous Melanoma from the Oncological Point of View
Gogas, H. J., Diamantopoulos, P. T., & Polyzos, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-18797-2_2
Functional Imaging of Immunotherapy: Response Criteria, Imaging Characteristics, and Novel Immunoimaging of Advanced Malignancies
Juarez, R., Taliaferro, A. S., & Behr, S. C. (2020) · Current Radiology Reports · doi:10.1007/s40134-020-00369-9
Association of The Cytotoxic T Lymphocyte Antigen-4 +49G/A Gene Polymorphism with Susceptibility to Malignant Bone TumorsPreprint
Guo, N., Wu, Y., & Hu, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-54235/v1
Estudo de interrupção de imatinibe em pacientes portadores de leucemia mieloide crônica fase crônica, com resposta molecular sustentada >sup<_>>/sup<0,01% pela escala internacional
Seguro, F. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-22072021-151951
Manipulating Immunological Checkpoints to Maximize Antitumor Immunity
Emens, L. A., Reilly, R. T., & Jaffee, E. M. (2006) · Humana Press eBooks · doi:10.1385/1-59745-011-1:331
References
(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.50022-7
Interferon Therapy
Moschos, S. J., & Kirkwood, J. M. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_18
Strategies to Target Tumor Immunosuppression
Koutsoumpli, G., Draghiciu, O., Nijman, H. W., Oyarce, C., & Daemen, T. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_5
CTLA ‐4
(2004) · Wiley eBooks · doi:10.1002/0471684228.egp02953
Human Evolution
Hofreiter, M. (2009) · Springer eBooks · doi:10.1007/978-3-540-37654-5_20 · Cited by 1
DNA Vaccines Against Cancer
Cohen, A. D., & Wolchok, J. D. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_9
Faculty Opinions recommendation of Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist.
Davidson, A. (2006) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1033735.387928
Cancer immunotherapy
Sygitowicz, G., & Sitkiewicz, D. (2020) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0013.7457
B7 and CD28 Families
Zang, X. (2014) · Springer eBooks · doi:10.1007/978-0-387-84828-0_30
Aktuelle Systemtherapie des metastasierten Harnblasenkarzinoms
Horn, T. D., Amsberg, G. V., Tauber, R., & Retz, M. (2017) · Der Onkologe · doi:10.1007/s00761-017-0295-6
Recent trends in cancer immunotherapy: Pathways and inhibitors
Vidya, G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90461-2.00001-8
Controle de tumores induzidos por HPV por imunoterapia baseada na associação de anticorpos monoclonais de bloqueio de vias imunossupressoras a uma vacina terapêutica capaz de ativar linfócitos T CD8>sup<+>/sup< citotóxico.
Sales, N. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2021.tde-12082022-174356
Tumor Microenvironment and Immunotherapy in Advanced Biliary Tract Cancers
Korkmaz, M., & Artaç, M. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_41
Tumor Immune Escape and Treatment
Wang, Y. (2022) · BIO Web of Conferences · doi:10.1051/bioconf/20225501010
Cancer Treatment Strategy by Fukushima Medical University Aims to Achieve
Suzuki, H. Y. (2022) · 福島医学雑誌 · doi:10.5387/fmedj.72.3_109

Authors: Egen, J. G., Kuhns, M. S., & Allison, J. P.
Affiliations: Howard Hughes Medical Institute (US)
Corresponding author: Allison, James P.
ORCID: Egen, Jackson G.
Kuhns, Michael S.
Allison, James P.
Venue: Nature Immunology
Publisher: Springer Science and Business Media LLC
Published: 2002-07
Volume: 3
Issue: 7
Pages: 611-618
ISSN: 1529-2908 (ISSN-L)
1529-2916
DOI: 10.1038/ni0702-611
OpenAlex: W2140460887
Cited by: 940
References: 93
Citations by year: 2026: 10 · 2025: 15 · 2024: 30 · 2023: 34 · 2022: 45 · 2021: 50 · 2020: 43 · 2019: 33 · 2018: 27 · 2017: 36 · 2016: 28 · 2015: 32 · 2014: 31 · 2013: 38 · 2012: 25
FWCI: 5.88
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Immunology (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
National Institutes of Health
National Cancer Institute (CA40041, R01CA057986, CA57986)
Topics: Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: CTLA-4, costimulatory receptors, CD28, T cell activation, T cell receptor signaling, T cell regulation, cancer immunotherapy, CTLA-4 blockade, immune checkpoint blockade
MeSH terms: Abatacept, Animals, Antigens, Differentiation, Cell Division, Colonic Neoplasms, Disease Models, Animal, Fibrosarcoma, Gene Expression Regulation, Humans, Immunotherapy, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Antigens, CD, Immunoconjugates, Mice, CTLA-4 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CTLA-4: new insights into its biological function and use in tumor immunotherapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks